No definition available.
Keratitis and keratoconjunctivitis in other diseases classified elsewhere
DOID EFO Endpoint Browser PheWeb
H7_KERATITISINOTH
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1421 |
4. Check minimum number of eventsNone |
1421 |
5. Include endpointsNone |
1421 |
6. Filter based on genotype QC (FinnGen only) |
1366 |
Control definitions (FinnGen only)
- Control exclude
- H7_SCLERACORNEA
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Keratitis and keratoconjunctivitis in other diseases classified elsewhere
based on the number of shared cases.
Similar with more cases:
- Keratitis
- Disorders of sclera, cornea, iris and ciliary body
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 9965 | 6270 | 3655 |
| Only index persons | 9295 | 5917 | 3378 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.15 | 0.18 | 0.10 |
| Only index persons | 0.19 | 0.22 | 0.13 |
| Median age at first event (years) | |||
| Whole population | 57.25 | 57.87 | 56.25 |
| Only index persons | 56.48 | 57.07 | 55.45 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1366 | 893 | 473 |
| Unadjusted period prevalence (%) | 0.28 | 0.32 | 0.22 |
| Median age at first event (years) | 58.07 | 55.54 | 62.84 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1421
- Matched controls
- 14210
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H19.2*B02.3
ICD-10 Finland
Keratitis and keratoconjunctivitis (interstitial) in zoster
2241.7
307.7
551
*
S01AD03
ATC
aciclovir; ophthalmic
37.7
307.7
436
165
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
1024.3
307.7
378
5
B02.3
ICD-10 Finland
Zoster ocular disease
134.4
266.4
134
11
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
18.8
249.2
206
127
H19.2*B30.0
ICD-10 Finland
Epidemic keratoconjunctivitis
+∞
229.6
214
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
6.0
215.2
1053
4573
H16.0
ICD-10 Finland
Corneal ulcer
22.0
212.0
161
82
H04.10
ICD-10 Finland
Dry eye syndrome
6.6
209.5
416
835
H19.3
ICD-10 Finland
Keratitis and keratoconjunctivitis in other diseases classified elsewhere
982.1
180.4
173
*
J05AB11
ATC
valaciclovir; oral
5.2
172.9
469
1229
H19.2
ICD-10 Finland
Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere
1506.5
142.2
136
*
J05AB01
ATC
aciclovir; systemic
4.1
141.6
579
2036
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
169.6
119.4
124
8
H19.1*B00.5
ICD-10 Finland
Herpesviral keratoconjunctivitis
605.0
114.7
112
*
S01XA18
ATC
ciclosporin; ophthalmic
26.1
113.0
79
32
H16.9
ICD-10 Finland
Keratitis, unspecified
171.8
106.9
111
7
B02.9
ICD-10 Finland
Zoster without complication
5.1
93.6
220
494
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.2
92.9
296
844
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
3.1
92.7
718
3561
P01BA02
ATC
hydroxychloroquine; oral
4.6
91.0
249
632
H22.0*B02.3
ICD-10 Finland
Zoster iridocyclitis
+∞
85.3
81
*
H03.1*B02.3
ICD-10 Finland
Zoster blepharitis
30.5
80.2
53
18
H16.2
ICD-10 Finland
Keratoconjunctivitis
364.7
70.3
70
*
S01GX01
ATC
cromoglicic acid; ophthalmic
2.8
58.7
396
1745
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.9
58.2
356
1490
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
4.2
56.4
164
430
B02.8
ICD-10 Finland
Zoster with other complications
14.2
52.1
48
35
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.2
50.2
232
825
L04AX01
ATC
azathioprine; systemic
4.9
49.3
113
245
L04AX03
ATC
methotrexate; systemic
3.2
45.6
201
693
H57.1
ICD-10 Finland
Ocular pain
5.2
43.2
92
187
H02AB06
ATC
prednisolone; systemic
2.1
42.8
774
5087
TCC40
NOMESCO Finland
Closure of lacrimal canaliculus with plug
55.1
40.7
48
9
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
8.9
39.8
50
58
H01.0
ICD-10 Finland
Blepharitis
3.5
39.6
145
444
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.5
38.9
145
449
H19.1
ICD-10 Finland
Herpesviral keratitis and keratoconjunctivitis
195.1
37.0
38
*
L04AA01
ATC
[U] ciclosporin
9.2
36.1
44
49
S01BA01
ATC
dexamethasone; ophthalmic
4.7
36.1
85
188
CG2S4
NOMESCO Finland
Photography of cornea
80.3
35.0
39
5
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
3.5
34.6
129
399
G53.0
ICD-10 Finland
Postzoster neuralgia
11.5
34.6
36
32
H01.80
ICD-10 Finland
Prolonged inflammation in the edge of the eyelid
11.9
34.4
35
30
L01BA01
ATC
methotrexate; systemic
4.4
34.3
89
213
S01BC03
ATC
diclofenac; ophthalmic
5.7
33.1
62
112
N03AX16
ATC
[U] pregabalin
2.1
32.4
400
2222
H20.1
ICD-10 Finland
Chronic iridocyclitis
324.1
32.0
32
*
S01GX05
ATC
lodoxamide; ophthalmic
7.3
30.6
45
63
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
30.3
575
3704
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.2
28.8
120
397
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.0
28.7
137
490
H10.4
ICD-10 Finland
Chronic conjunctivitis
7.8
28.1
39
51
H15.1
ICD-10 Finland
Episcleritis
27.8
28.1
38
14
S01BA07
ATC
fluorometholone; ophthalmic
6.6
26.5
43
67
S01AA01
ATC
chloramphenicol; ophthalmic
3.3
26.4
104
332
H10.5
ICD-10 Finland
Blepharoconjunctivitis
5.4
26.4
53
102
S01ED51
ATC
timolol, combinations; ophthalmic
2.8
26.1
145
563
B00.5
ICD-10 Finland
Herpesviral ocular disease
40.9
25.9
32
8
L88
ICPC
Rheumatoid/seropositive arthritis
3.7
25.7
83
233
B02
ICD-10 Finland
Zoster [herpes zoster]
3.3
25.5
102
329
S01BA04
ATC
prednisolone; ophthalmic
5.4
25.0
50
96
G53.0*B02.20
ICD-10 Finland
Trigeminal neuralgia after shingles
26.7
24.9
34
13
N03AX12
ATC
[U] gabapentin; oral
2.1
24.8
282
1501
L04AB01
ATC
etanercept; parenteral
6.7
24.4
39
60
S01KA02
ATC
hypromellose; ophthalmic
4.9
24.0
53
111
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
4.6
24.0
57
127
S01ED01
ATC
timolol; ophthalmic
3.8
23.7
74
203
J01DB01
ATC
cefalexin; oral
2.1
23.5
1179
9970
S01AX11
ATC
[U] ofloxacin
3.6
23.1
79
230
H02AB04
ATC
methylprednisolone; systemic
2.1
23.0
242
1248
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.5
22.8
79
232
S01FA04
ATC
cyclopentolate; ophthalmic
9.5
22.7
27
29
N02AX02
ATC
tramadol; systemic, rectal
1.7
22.6
636
4505
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
4.4
22.4
57
134
A07EC01
ATC
sulfasalazine; oral, rectal
2.6
21.4
134
551
R51.80
ICD-10 Finland
Headache
2.1
21.2
245
1307
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
4.4
21.0
53
124
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.6
20.9
124
497
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
20.8
674
4926
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.1
20.8
92
315
286
Kela drug reimbursment
Ciclosporin eye drop
111.7
20.6
22
*
A07AA02
ATC
nystatin; oral
2.7
19.9
109
419
L04AA06
ATC
mycophenolic acid; systemic
5.2
19.8
41
81
H17.1
ICD-10 Finland
Other central corneal opacity
+∞
19.8
19
*
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.4
19.6
71
215
H13.1*B02.3
ICD-10 Finland
Zoster conjunctivitis
202.7
19.6
20
*
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
2.6
18.9
114
460
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.3
18.9
159
747
E0000UV, ,
ATC
1.7
18.8
597
4306
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.1
18.7
80
268
H17.8
ICD-10 Finland
Other corneal scars and opacities
192.4
18.6
19
*
J01MA02
ATC
ciprofloxacin; systemic
1.7
18.4
563
4017
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
18.4
529
3714
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
18.3
340
2112
S01EC01
ATC
acetazolamide; systemic
4.6
18.3
44
99
CG2T4
NOMESCO Finland
Topography assessment of cornea
17.8
18.3
28
16
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
3.9
18.2
54
143
L04AA13
ATC
[U] leflunomide
4.0
18.0
52
135
R06AE07
ATC
cetirizine; oral
1.6
17.9
622
4573
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.2
17.8
164
799
CG2X4
NOMESCO Finland
Optical coherence tomography (OCT) of cornea
23.1
17.8
25
11
CCC00
NOMESCO Finland
Occlusion of lacrimal punctum or canaliculus
+∞
17.7
17
*
S01GX09
ATC
olopatadine; ophthalmic
3.6
17.6
58
165
F29
ICPC
Eye symptom/complaint other
2.2
17.5
150
710
R06.0
ICD-10 Finland
Dyspnoea
1.7
17.2
405
2686
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.8
16.8
290
1757
B30.0
ICD-10 Finland
Keratoconjunctivitis due to adenovirus
+∞
16.7
16
*
H22.0*B00.5
ICD-10 Finland
Herpesviral iridocyclitis
+∞
16.7
16
*
H03.1*B00.5
ICD-10 Finland
Herpesviral dermatitis of eyelid
20.3
16.4
24
12
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.9
16.4
222
1244
ZXA00
NOMESCO Finland
Right side
1.7
16.2
397
2656
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
30.4
16.1
21
7
H02AB07
ATC
prednisone; oral
1.9
16.0
216
1209
A02BC02
ATC
pantoprazole; systemic
1.6
15.9
956
7932
B00.10
ICD-10 Finland
Herpes simplex facialis
6.4
15.9
26
41
F01
ICPC
Eye pain
3.6
15.8
52
148
XCK00
NOMESCO Finland
Perimetry
2.5
15.8
103
432
H10.2
ICD-10 Finland
Other acute conjunctivitis
5.1
15.8
33
66
L04AD01
ATC
ciclosporin; systemic
4.5
15.7
38
86
S70
ICPC
Herpes zoster
3.4
15.7
56
168
ZXE00
NOMESCO Finland
One hour or less
1.6
15.7
549
4007
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
7.3
15.7
23
32
M01CB01
ATC
sodium aurothiomalate; parenteral
5.0
15.5
33
67
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
15.5
542
3954
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
3.4
15.4
56
170
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
7.1
15.3
23
33
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.1
15.1
154
779
H16.1
ICD-10 Finland
Other superficial keratitis without conjunctivitis
45.5
15.1
18
*
A02BC01
ATC
omeprazole; systemic
1.7
15.0
394
2673
ZXA05
NOMESCO Finland
Left side
1.7
14.9
368
2456
M79.7
ICD-10 Finland
Fibromyalgia
3.0
14.7
67
233
SBA10
NOMESCO Finland
Measurement of salivary flow rate
5.4
14.7
29
55
S01EA05
ATC
brimonidine; ophthalmic
3.6
14.7
48
136
H17.9
ICD-10 Finland
Corneal scar and opacity, unspecified
+∞
14.6
14
*
H13.1*B30.1
ICD-10 Finland
Conjunctivitis due to adenovirus
81.0
14.6
16
*
H16.8
ICD-10 Finland
Other keratitis
81.0
14.6
16
*
H18.8
ICD-10 Finland
Other specified disorders of cornea
81.0
14.6
16
*
M01CB03
ATC
auranofin; oral
6.4
14.6
24
38
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
14.5
496
3584
N06AX11
ATC
mirtazapine; oral
1.6
14.5
479
3436
G73.7*M35.0
ICD-10 Finland
Myopathy in sicca syndrome [Sjögren]
36.4
14.5
18
5
R03AC02
ATC
salbutamol; inhalant
1.5
14.4
763
6084
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.2
14.3
134
656
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
4.9
14.3
31
64
H02.0
ICD-10 Finland
Entropion and trichiasis of eyelid
3.8
14.3
43
115
TEA00
NOMESCO Finland
Biopsy of lip
5.7
14.2
26
46
N02BE01
ATC
paracetamol; systemic, rectal
1.9
14.2
1255
11324
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
14.1
418
2916
Z3229
NOMESCO Finland
Other healthcare associate professional
2.2
14.1
129
626
M45
ICD-10 Finland
Ankylosing spondylitis
4.6
14.0
33
73
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
14.0
281
1772
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
14.0
191
1072
H03.1
ICD-10 Finland
Involvement of eyelid in other infectious diseases classified elsewhere
30.4
13.9
18
6
127
Kela drug reimbursment
Transplant complication
4.9
13.8
30
62
Z3231
NOMESCO Finland
Registered nurse
1.6
13.8
382
2619
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
13.8
276
1738
H10
ICD-10 Finland
Conjunctivitis
2.3
13.7
105
474
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
13.7
170
924
J01FF01
ATC
clindamycin; systemic
1.6
13.6
376
2577
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
13.3
224
1340
XCH00
NOMESCO Finland
Eye pressure measurement
2.6
13.3
78
311
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
2.9
13.2
61
214
H11.1
ICD-10 Finland
Conjunctival degenerations and deposits
9.8
13.2
26
27
J01AA02
ATC
doxycycline; systemic
1.6
13.2
1080
9399
N06AX21
ATC
duloxetine; oral
1.9
13.1
178
995
S01GX04
ATC
nedocromil; ophthalmic
4.1
13.1
36
90
S01GX08
ATC
ketotifen; ophthalmic
2.6
13.1
75
295
M79.6
ICD-10 Finland
Pain in limb
1.5
13.1
579
4410
R05
ICD-10 Finland
Cough
1.7
13.0
294
1912
M05BA04
ATC
alendronic acid; oral
2.0
12.8
151
805
R4110
NOMESCO Finland
Physiotherapy
1.6
12.8
385
2685
A02BC05
ATC
esomeprazole; systemic
1.5
12.8
568
4322
R50.9
ICD-10 Finland
Fever, unspecified
1.8
12.7
208
1233
A02BC03
ATC
lansoprazole; oral
1.6
12.7
412
2924
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
12.6
352
2409
H20.8
ICD-10 Finland
Other iridocyclitis
70.5
12.6
14
*
XCK10
NOMESCO Finland
Photography of fundus of eye
2.0
12.6
141
738
J01FA10
ATC
azithromycin; systemic
1.5
12.5
763
6190
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
3.1
12.5
53
177
J01MA12
ATC
levofloxacin; systemic
1.7
12.5
265
1690
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.9
12.5
181
1033
ZXA10
NOMESCO Finland
Bilateral
1.7
12.5
264
1683
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.5
12.5
460
3359
XX9XE
NOMESCO Finland
Other ultrasound examination
5.7
12.4
23
41
A01AB09
ATC
miconazole; local oral
2.0
12.4
138
720
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.9
12.3
166
926
E000001, ,
ATC
1.7
12.3
271
1747
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
12.3
245
1537
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
3.9
12.2
36
95
H18.4
ICD-10 Finland
Corneal degeneration
37.9
12.2
15
*
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.0
12.2
132
683
Z71.8
ICD-10 Finland
Other specified counselling
1.6
12.1
404
2879
H53.1
ICD-10 Finland
Subjective visual disturbances
2.2
12.0
100
467
M01AH01
ATC
celecoxib; oral
1.7
12.0
259
1659
R53
ICD-10 Finland
Malaise and fatigue
1.6
11.9
337
2312
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
4.4
11.7
29
67
H03AA01
ATC
levothyroxine sodium; systemic
1.6
11.6
343
2374
H13.1
ICD-10 Finland
Conjunctivitis in infectious and parasitic diseases classified elsewhere
65.5
11.6
13
*
G53.0*B02.21
ICD-10 Finland
Postherpetic geniculate ganglionitis
23.1
11.6
16
7
J01FA06
ATC
roxithromycin; oral
1.5
11.6
553
4249
Z2221
NOMESCO Finland
Medical doctor
1.6
11.6
380
2696
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.9
11.4
152
845
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.1
11.3
112
560
A01
ICPC
Pain general/multiple sites
1.9
11.1
137
741
SBA00
NOMESCO Finland
Microbiological examinations
3.2
11.0
44
142
F03
ICPC
Eye discharge
2.2
11.0
92
430
J02AC01
ATC
fluconazole; systemic
1.5
11.0
535
4112
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.0
11.0
129
686
H02AB09
ATC
hydrocortisone; systemic
3.3
10.9
40
123
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
10.9
603
4756
Z3226
NOMESCO Finland
Physiotherapist
1.6
10.8
255
1670
R01AD09
ATC
mometasone; nasal
1.5
10.8
604
4771
E000002, ,
ATC
1.9
10.7
146
816
R06AX27
ATC
desloratadine; oral
1.5
10.7
366
2614
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.6
10.5
60
236
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.8
10.5
53
196
D07AB02
ATC
hydrocortisone butyrate; topical
1.5
10.5
393
2860
Z94.7
ICD-10 Finland
Corneal transplant status
+∞
10.4
10
*
N02BF02
ATC
pregabalin; oral
2.2
10.4
90
427
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.4
10.4
73
317
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
10.4
304
2094
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
10.4
677
5490
R52.9
ICD-10 Finland
Pain, unspecified
1.9
10.4
138
766
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.0
10.4
110
565
J01DA01
ATC
[U] cefalexin
1.5
10.3
843
7124
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
10.3
352
2509
E000006, ,
ATC
2.1
10.3
102
511
ZX120
NOMESCO Finland
Intravenous
1.9
10.2
131
718
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.6
10.2
58
228
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.3
10.0
37
114
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.2
10.0
89
428
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
10.0
367
2657
G44.2
ICD-10 Finland
Tension-type headache
1.7
9.9
189
1167
N06AX16
ATC
venlafaxine; oral
1.7
9.9
191
1185
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
9.9
534
4170
L04AA11
ATC
[U] etanercept
12.3
9.9
17
14
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
9.8
589
4687
M54.5
ICD-10 Finland
Low back pain
1.5
9.8
472
3606
TGC00
NOMESCO Finland
Bronchial lavation
3.0
9.7
42
143
R03DC03
ATC
montelukast; oral
1.6
9.7
229
1498
7102A
ICD-9 Finland
Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM PRIMARIUM]
55.4
9.7
11
*
M25.5
ICD-10 Finland
Pain in joint
1.5
9.6
423
3170
N06AA09
ATC
amitriptyline; systemic
1.8
9.6
144
829
S01EC04
ATC
brinzolamide; ophthalmic
2.4
9.6
63
266
J01MA14
ATC
moxifloxacin; systemic
1.9
9.6
128
712
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
9.5
183
1133
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.1
9.4
39
129
N06AB04
ATC
citalopram; systemic
1.6
9.4
286
1982
H15.0
ICD-10 Finland
Scleritis
+∞
9.4
9
*
H16.4
ICD-10 Finland
Corneal neovascularization
+∞
9.4
9
*
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
5.2
9.4
19
37
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
5.2
9.4
19
37
WX002
NOMESCO Finland
Sedation and analgesia
1.6
9.4
263
1791
S01EX03, ,
ATC
3.2
9.4
36
114
K07.60
ICD-10 Finland
Snapping jaw
2.2
9.4
74
339
K11.70
ICD-10 Finland
Hypoptyalism
8.1
9.3
20
25
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
9.3
376
2767
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.4
9.3
66
288
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.9
9.3
123
681
M54.4
ICD-10 Finland
Lumbago with sciatica
1.6
9.2
237
1579
WW200
NOMESCO Finland
Immunization
3.0
9.2
40
136
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
3.2
9.2
35
110
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.7
9.2
187
1175
J01FA09
ATC
clarithromycin; systemic
1.5
9.2
400
2988
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.1
9.2
90
449
TCC10
NOMESCO Finland
Probing of lacrimal canaliculus/duct
7.8
9.1
20
26
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.0
9.1
105
555
S01EA03
ATC
apraclonidine; ophthalmic
5.1
9.1
19
38
SHA04
NOMESCO Finland
Stomatognathic treatment, very demanding
4.5
9.1
22
50
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
3.5
9.1
30
86
N02BF01
ATC
gabapentin; oral
1.9
9.1
120
665
H18.5
ICD-10 Finland
Hereditary corneal dystrophies
36.9
9.0
11
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
9.0
112
608
S76
ICPC
Skin infection other
2.2
9.0
76
358
R20.2
ICD-10 Finland
Paraesthesia of skin
2.0
9.0
94
481
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
3.2
8.9
34
107
R03AC03
ATC
terbutaline; inhalant
1.7
8.9
194
1240
S18
ICPC
Laceration/cut
1.4
8.9
596
4811
J01EA01
ATC
trimethoprim; systemic
1.5
8.9
369
2730
H25.1
ICD-10 Finland
Senile nuclear cataract
1.5
8.8
380
2830
P01AB01
ATC
metronidazole; oral, rectal
1.4
8.8
534
4236
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.8
8.8
134
776
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
8.8
286
2012
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
50.3
8.7
10
*
XKD00
NOMESCO Finland
Uroflowmetry
1.7
8.6
174
1090
C08CA05
ATC
nifedipine; systemic
2.0
8.6
88
446
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
4.8
8.6
19
40
S01GX02
ATC
levocabastine; ophthalmic
2.1
8.6
84
419
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.0
8.5
97
511
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.3
8.5
65
294
TCG00
NOMESCO Finland
Protection of cornea and sclera with soft lens
27.7
8.5
11
*
H26.2
ICD-10 Finland
Complicated cataract
4.2
8.5
22
53
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
2.1
8.4
75
361
SBB10
NOMESCO Finland
Dental impressions
2.1
8.4
81
402
R01AD08
ATC
fluticasone; nasal
1.5
8.4
364
2711
H18.2
ICD-10 Finland
Other corneal oedema
+∞
8.3
8
*
H192, B005,
ICD-10 Finland
+∞
8.3
8
*
H53.9
ICD-10 Finland
Visual disturbance, unspecified
2.5
8.3
52
215
L04AA24
ATC
abatacept; parenteral
10.8
8.3
15
14
M03BX02
ATC
tizanidine; oral
1.4
8.3
798
6821
N03AX09
ATC
lamotrigine; oral
2.3
8.3
62
278
S01EE05
ATC
tafluprost; ophthalmic
2.4
8.3
55
234
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.3
8.2
58
253
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.1
8.2
81
405
J31.0
ICD-10 Finland
Chronic rhinitis
1.8
8.2
113
634
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.0
8.2
91
475
TCG10
NOMESCO Finland
Removal of sutures from cornea
14.6
8.2
13
9
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
8.2
370
2775
N05CF01
ATC
zopiclone; oral
1.4
8.1
437
3382
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
4.6
8.1
19
42
H26.4
ICD-10 Finland
After-cataract
1.7
8.1
142
857
C03CA01
ATC
furosemide; systemic
1.4
8.1
411
3150
S01EE01
ATC
latanoprost; ophthalmic
1.9
7.9
92
488
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
2.9
7.9
36
126
Z2446
NOMESCO Finland
Social worker
1.9
7.9
92
489
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
7.9
459
3601
M79.1
ICD-10 Finland
Myalgia
1.6
7.8
189
1239
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
3.8
7.8
23
61
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.8
7.8
121
705
S01FA02
ATC
scopolamine; ophthalmic
9.5
7.8
15
16
R06AX13
ATC
loratadine; oral
1.6
7.8
194
1283
J01AA07
ATC
tetracycline; systemic
1.6
7.7
193
1275
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.8
7.7
123
722
R01BA52
ATC
pseudoephedrine, combinations; oral
1.4
7.6
388
2967
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
7.6
159
1005
D06BX01
ATC
metronidazole; topical
1.7
7.6
149
926
S29
ICPC
Skin symptom/complaint other
1.5
7.6
243
1697
R51.81
ICD-10 Finland
Facial pain NOS
2.8
7.6
37
135
WX140
NOMESCO Finland
Parabulbar anesthesy
2.2
7.6
64
302
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
7.6
917
8078
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.3
7.6
56
250
D07AC01
ATC
betamethasone; topical
1.4
7.6
454
3574
M01AH05
ATC
etoricoxib; oral
1.4
7.5
793
6830
R02
ICPC
Shortness of breath/dyspnoea
1.6
7.5
168
1081
B07.9
ICD-10 Finland
Verruca simplex
2.5
7.5
47
195
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
7.5
259
1841
N03AF01
ATC
carbamazepine; oral, rectal
2.0
7.4
75
379
ZXE20
NOMESCO Finland
More than three and less than five hours
1.6
7.4
176
1149
N80.0
ICD-10 Finland
Endometriosis of uterus
3.0
7.4
32
109
121
Kela drug reimbursment
Severe hypofunction of sexual glands
2.9
7.4
34
120
K11.2
ICD-10 Finland
Sialoadenitis
2.5
7.4
46
190
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.8
7.4
107
611
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
7.3
691
5839
H00.1
ICD-10 Finland
Chalazion
2.3
7.3
52
228
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.0
7.3
75
381
R4190
NOMESCO Finland
Nutritional therapy
2.4
7.3
47
197
H19.0*B02.3
ICD-10 Finland
Zoster scleritis
+∞
7.3
7
*
H18.9
ICD-10 Finland
Disorder of cornea, unspecified
+∞
7.3
7
*
A05AA02
ATC
ursodeoxycholic acid; oral
3.3
7.3
27
84
L29
ICPC
Musculoskeletal sympt/complt other
1.8
7.2
115
675
D07AC13
ATC
mometasone; topical
1.4
7.2
372
2848
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
7.2
476
3800
L17
ICPC
Foot/toe symptom/complaint
1.4
7.2
367
2804
L20.0
ICD-10 Finland
Besnier prurigo
1.9
7.2
84
447
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.8
7.2
108
623
114
Kela drug reimbursment
Glaucoma
1.7
7.2
120
714
A01AB04
ATC
amphotericin B; local oral
2.0
7.2
74
377
D06BB03
ATC
aciclovir; topical
2.1
7.2
67
329
S01ED02
ATC
betaxolol; ophthalmic
4.0
7.2
20
51
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
3.6
7.2
23
65
G73.7
ICD-10 Finland
Myopathy in other diseases classified elsewhere
30.2
7.2
9
*
M01AC06
ATC
meloxicam; systemic, rectal
1.4
7.1
479
3833
7102B
ICD-9 Finland
Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM SECUNDARIUM]
20.1
7.1
10
5
D07AA02
ATC
hydrocortisone; topical
1.6
7.1
171
1119
NHQ40
NOMESCO Finland
Amputation of toe
3.4
7.1
25
75
R68.2
ICD-10 Finland
Dry mouth, unspecified
6.6
7.1
17
26
H02.1
ICD-10 Finland
Ectropion of eyelid
4.1
7.1
19
47
L04AA17
ATC
[U] adalimumab
12.1
7.1
12
10
N02AA05
ATC
oxycodone; systemic
1.5
7.1
232
1629
ELA30
NOMESCO Finland
Biopsy of salivary gland
8.8
7.1
14
16
F02
ICPC
Red eye
2.3
7.0
54
245
SAA04
NOMESCO Finland
Special examination of mouth
2.0
7.0
71
359
Z01.9
ICD-10 Finland
Special examination, unspecified
1.9
7.0
82
437
T78.4
ICD-10 Finland
Allergy, unspecified
2.2
7.0
58
272
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
7.0
349
2656
J01CA04
ATC
amoxicillin; systemic
1.4
7.0
1072
9745
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
3.0
6.9
29
97
M05BA01
ATC
etidronic acid; systemic
5.9
6.9
18
31
N06AB10
ATC
escitalopram; oral
1.5
6.9
247
1764
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.1
6.9
28
92
K12.00
ICD-10 Finland
Recurrent oral aphthae
3.5
6.9
23
67
R96
ICPC
Asthma
1.7
6.8
129
794
SPAT1325
SPAT
Vaccination
1.4
6.8
432
3418
S01
ICPC
Pain/tenderness of skin
2.1
6.8
63
308
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.0
6.8
68
343
R01AD58
ATC
fluticasone, combinations; nasal
1.4
6.8
284
2091
R60.9
ICD-10 Finland
Oedema, unspecified
2.0
6.8
74
385
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
6.8
157
1019
N30.9
ICD-10 Finland
Cystitis, unspecified
1.9
6.8
85
464
H04.3
ICD-10 Finland
Acute and unspecified inflammation of lacrimal passages
5.7
6.8
18
32
S01GX06
ATC
emedastine; ophthalmic
3.7
6.8
21
58
M34.0
ICD-10 Finland
Progressive systemic sclerosis
40.2
6.8
8
*
R03AK07
ATC
formoterol and budesonide; inhalant
1.5
6.7
258
1868
C10AC01
ATC
colestyramine; oral
2.5
6.7
39
156
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
6.7
906
8036
SPAT1260
SPAT
Consultation of another employee
1.5
6.7
221
1552
H13.1*B00.5
ICD-10 Finland
Herpesviral conjunctivitis
22.6
6.7
9
*
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.7
6.7
118
714
M04AA01
ATC
allopurinol; systemic
1.6
6.7
159
1039
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.8
6.6
106
623
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
3.1
6.6
27
89
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.8
6.6
107
631
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.8
6.6
103
601
D11AH01
ATC
tacrolimus; topical
5.5
6.6
18
33
L84
ICD-10 Finland
Corns and callosities
2.3
6.6
50
226
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
6.6
140
889
D02AX
ATC
Other emollients and protectives
2.4
6.6
43
182
H20
ICD-10 Finland
Iridocyclitis
12.3
6.6
11
9
M03BC51
ATC
orphenadrine, combinations; systemic
1.4
6.6
342
2618
NDL52
NOMESCO Finland
Tenosynovectomy of hand
4.2
6.6
17
41
M01AH02
ATC
rofecoxib; oral
1.6
6.5
173
1158
SPAT1301
SPAT
No procedures
1.4
6.5
398
3128
H26.3
ICD-10 Finland
Drug-induced cataract
6.9
6.5
15
22
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
6.5
167
1110
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
6.5
180
1217
UJF32
NOMESCO Finland
Coloscopy
1.4
6.5
332
2532
M02AA07
ATC
piroxicam; topical
1.4
6.5
468
3775
J01DC02
ATC
cefuroxime; systemic
2.0
6.5
71
370
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
2.6
6.5
35
135
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.5
6.5
39
159
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
5.7
6.5
17
30
SXA10
NOMESCO Finland
Oral mucosal sampling
3.5
6.4
21
60
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.9
6.4
78
421
Z01.2
ICD-10 Finland
Dental examination
1.3
6.4
545
4506
NDG77
NOMESCO Finland
Other excision, reconstruction or fusion of joint of first finger
14.4
6.4
10
7
TQW99
NOMESCO Finland
Other minor procedure on skin
2.0
6.4
70
365
U05
ICPC
Urination problems other
2.0
6.4
67
344
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
2.0
6.4
68
351
J01DA06
ATC
[U] cefuroxime
1.5
6.4
182
1239
I50.9
ICD-10 Finland
Heart failure, unspecified
1.5
6.4
184
1256
Z49.1
ICD-10 Finland
Extracorporeal dialysis
3.8
6.4
19
51
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
6.4
380
2975
J01AA04
ATC
lymecycline; systemic
1.6
6.3
157
1035
D11AX14
ATC
[U] tacrolimus
8.2
6.3
13
16
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.6
6.3
149
971
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.4
6.3
286
2135
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic
5.5
6.3
17
31
G43.9
ICD-10 Finland
Migraine, unspecified
1.9
6.3
71
374
L04AB04
ATC
adalimumab; parenteral
2.9
6.3
29
103
TCF00
NOMESCO Finland
Subconjunctival therapeutic injection
18.1
6.3
9
5
R01AD12
ATC
fluticasone furoate; nasal
1.4
6.3
371
2899
N30.0
ICD-10 Finland
Acute cystitis
1.5
6.3
212
1497
CGG45
NOMESCO Finland
Full thickness transplantation of cornea using homograft
+∞
6.3
6
*
H16.3
ICD-10 Finland
Interstitial and deep keratitis
+∞
6.3
6
*
H191, B023,
ICD-10 Finland
+∞
6.3
6
*
H40.4
ICD-10 Finland
Glaucoma secondary to eye inflammation
+∞
6.3
6
*
H04.1
ICD-10 Finland
Other disorders of lacrimal gland
+∞
6.3
6
*
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.7
6.2
104
619
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
6.2
231
1660
UKC02
NOMESCO Finland
Cystoscopy
1.5
6.2
191
1321
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
2.5
6.2
36
144
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
6.2
125
783
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
6.2
203
1424
UJH02
NOMESCO Finland
Anoscopy
2.1
6.1
57
280
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
6.1
143
931
D51.9
ICD-10 Finland
Vitamin B12deficiency anaemia, unspecified
3.8
6.1
18
48
Z94.0
ICD-10 Finland
Kidney transplant status
4.1
6.1
16
39
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
4.1
6.1
16
39
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.8
6.1
90
518
CBG00
NOMESCO Finland
Epilation of cilia by electrolysis
8.6
6.1
12
14
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
2.4
6.0
41
177
SPA10
NOMESCO Finland
Setting attachments on tooth or implanted bracket or imblant based structures
10.1
6.0
11
11
L71.8
ICD-10 Finland
Other rosacea
3.0
6.0
26
89
XQ802
NOMESCO Finland
Epicutan test
2.1
6.0
51
242
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
77
90
8.99
61.11
1.2
1.2
—
—
—
0
0
50
45
11.48
47.73
1.3
1.2
—
—
—
0
0
119
342
3.71
35.65
2.2
1.5
1.16
1.21
g/l
0.82
113
321
920
6719
2.05
35.27
13.1
8.7
4.04
4.08
e9/l
0.18
847
5866
114
330
3.67
33.77
2.3
1.5
0.22
0.24
g/l
1.89
107
311
131
421
3.33
33.01
1.5
1.2
0.70
1.03
u/ml
—
9
31
199
839
2.60
30.57
4.3
2.7
11.17
10.60
g/l
0.72
183
761
765
5398
1.90
30.52
10.2
5.6
2.87
2.83
%
0.20
739
5018
777
5564
1.87
29.06
10.2
5.7
27.14
27.65
%
0.62
755
5194
762
5482
1.84
27.48
9.9
5.4
57.84
57.38
%
0.49
739
5114
805
5901
1.84
27.20
8.9
6.2
1.22
1.22
mmol/l
0.07
675
4989
536
3476
1.87
26.83
4.1
3.2
19.86
84.43
e6/l
2.72
431
2675
603
4079
1.83
26.19
5.0
3.6
69.04
111.97
e6/l
0.95
465
2879
744
5365
1.81
26.12
7.9
5.6
1.21
1.21
mmol/l
0.23
684
4873
83
236
3.67
25.19
1.4
1.2
71.49
57.66
u/ml
0.23
13
23
1066
8636
1.94
25.17
6.3
4.0
14.04
12.62
mm/h
2.25
1001
7926
99
317
3.28
25.02
1.5
1.2
50.77
42.78
u/ml
0.12
18
16
771
5680
1.78
24.61
6.7
5.0
0.00
0.00
estimate
0.50
188
1076
775
5740
1.77
24.08
5.2
3.7
0.00
0.01
estimate
1.08
187
1042
156
661
2.53
23.50
2.5
1.7
1.30
1.48
g/l
0.57
144
609
764
5667
1.75
23.31
5.2
3.7
0.00
0.00
estimate
0.75
202
1151
39
63
6.34
23.26
2.5
2.2
—
—
—
0
0
316
1808
1.96
22.55
3.1
2.3
13.41
12.93
umol/l
0.58
292
1683
689
5046
1.71
21.30
3.5
2.7
143.24
123.05
ug/l
0.72
651
4631
481
3199
1.76
20.98
4.0
3.1
0.49
0.49
e6/l
0.00
385
2442
692
5089
1.70
20.95
5.7
4.5
35.28
35.41
g/l
0.25
643
4715
50
112
4.59
20.90
1.2
1.1
—
—
—
0
0
87
292
3.11
20.32
1.5
1.2
2.04
2.50
u/ml
0.33
11
28
88
299
3.07
20.13
1.5
1.2
2.16
9.32
u/ml
1.10
16
48
273
1548
1.95
19.75
3.3
2.4
22.36
22.32
%
0.02
250
1325
71
214
3.44
19.74
4.8
6.0
341.71
268.23
iu/ml
—
7
30
286
1654
1.91
19.48
3.1
2.3
2.32
2.34
g/l
0.31
268
1537
1074
8994
1.79
19.43
10.8
7.4
79.12
78.55
u/l
0.10
1034
8440
73
227
3.34
19.33
1.4
1.2
1.90
6.26
u/ml
—
6
18
386
2459
1.78
19.24
3.0
2.6
4.57
6.39
e6/l
2.03
354
2216
458
3073
1.72
18.97
5.6
4.0
0.00
0.01
estimate
1.08
186
1041
53
136
4.01
18.61
1.5
1.3
57.00
53.97
u/ml
—
5
7
658
4901
1.64
18.03
2.8
2.3
80.33
77.86
nmol/l
1.37
603
4370
315
1933
1.81
17.60
3.3
2.7
1.25
1.24
e6/l
0.01
201
1098
297
1802
1.82
17.19
3.7
2.9
2.90
2.94
e6/l
0.02
183
972
91
352
2.69
16.43
2.1
1.8
—
—
—
0
0
38
85
4.57
15.94
1.2
1.2
—
—
—
0
0
38
85
4.57
15.94
1.2
1.2
—
—
—
0
0
302
1885
1.76
15.75
3.7
3.1
0.82
0.82
mmol/l
0.13
285
1760
38
86
4.51
15.71
1.2
1.2
—
—
—
0
0
38
86
4.51
15.71
1.2
1.2
—
—
—
0
0
38
86
4.51
15.71
1.2
1.2
—
—
—
0
0
1282
11581
2.09
15.52
22.9
14.2
20.67
23.89
mg/l
3.45
1099
9174
90
358
2.62
15.38
1.9
1.6
404.00
148.00
titre
—
10
15
227
1311
1.87
15.25
3.6
2.5
1.87
1.80
%
0.42
217
1165
79
297
2.76
15.07
2.4
2.2
11.13
12.58
mg/l
0.85
74
267
433
3008
1.63
15.03
2.6
2.1
3.03
3.06
mg/l
0.11
380
2535
178
952
1.99
15.02
2.6
2.8
67.07
66.59
g/l
0.34
164
868
932
7754
1.59
14.71
6.1
4.6
1305.15
2693.54
e6/l
0.69
27
112
489
3522
1.59
14.52
2.4
2.1
165.85
229.77
u/l
1.23
460
3291
308
1991
1.70
13.99
1.4
1.3
114.42
36.31
iu/ml
0.56
102
659
550
4098
1.56
13.96
3.9
3.4
2.35
2.36
mmol/l
0.25
483
3595
327
2170
1.66
13.38
2.1
1.4
2.43
2.46
g/l
0.06
221
1306
478
3490
1.56
13.08
3.8
3.0
1481.73
1405.70
ng/l
0.18
407
2952
578
4400
1.53
13.07
5.5
3.9
—
—
—
0
0
1046
9044
1.59
13.06
4.9
4.1
14.95
14.80
pmol/l
1.20
973
8201
102
467
2.28
12.85
2.7
2.0
38.28
39.60
u/l
0.28
96
407
175
983
1.89
12.72
4.6
3.7
1.22
1.23
mmol/l
0.56
156
838
1125
9949
1.63
12.25
25.1
16.9
14.88
14.93
%
0.11
1110
9754
618
4829
1.50
12.04
2.3
2.0
98.02
95.82
pmol/l
0.48
323
2460
75
311
2.49
11.79
1.5
1.7
—
—
—
0
0
59
218
2.78
11.67
3.3
3.0
3.98
4.36
e9/l
0.58
59
218
747
6093
1.48
11.57
7.5
6.1
11.42
11.24
umol/l
0.09
701
5783
394
2818
1.55
11.56
1.6
1.5
20.42
20.88
nmol/l
0.25
347
2385
208
1272
1.74
11.38
6.6
3.9
253.45
248.81
u/l
0.17
200
1203
60
227
2.72
11.36
3.5
3.3
58.22
59.32
%
0.27
60
227
168
968
1.83
11.23
3.3
2.5
69.99
70.44
e9/l
0.05
133
743
182
1084
1.78
10.90
2.6
2.0
342.64
379.21
nmol/l
1.81
170
990
674
5433
1.46
10.82
17.1
15.9
1.26
1.27
inr
0.19
218
1557
210
1317
1.70
10.46
2.5
2.2
128.52
128.82
ug/g
0.00
169
1043
397
2903
1.51
10.32
4.8
3.7
91.03
90.70
%
0.09
386
2825
282
1922
1.58
10.06
1.3
1.3
28.89
13.11
u/ml
0.57
103
720
64
266
2.47
10.05
2.0
1.6
—
—
—
0
0
84
394
2.20
10.01
2.7
2.8
0.89
1.12
g/l
0.26
75
351
809
6816
1.43
9.86
5.7
4.5
6.63
6.71
mmol/l
0.48
771
6398
49
180
2.78
9.84
1.4
1.4
120.25
111.70
u/ml
0.36
12
31
482
3708
1.45
9.58
3.4
3.1
29.10
32.86
u/l
1.95
457
3531
26
65
4.06
9.53
1.2
1.2
—
—
—
0
0
44
156
2.88
9.44
2.1
1.5
—
—
—
0
0
73
334
2.25
9.25
1.5
1.6
0.01
20.44
iu/ml
—
10
59
318
2266
1.52
9.21
3.5
3.0
2.45
2.45
mmol/l
0.19
276
1988
76
355
2.21
9.17
2.9
2.6
0.02
0.01
g/l
0.09
71
329
50
193
2.65
9.15
2.0
1.5
—
—
—
0
0
51
199
2.62
9.14
2.2
1.7
—
—
—
0
0
50
195
2.62
8.97
1.2
1.2
—
—
—
0
0
1181
10788
1.56
8.89
5.8
4.8
1.86
2.03
mu/l
0.80
1111
9829
89
452
2.03
8.66
2.6
2.5
3.68
3.63
g/l
0.15
82
413
159
972
1.72
8.65
11.3
6.9
9.77
9.91
mmol/l
0.10
152
923
89
453
2.03
8.61
2.6
2.5
7.15
7.40
g/l
0.78
82
413
89
453
2.03
8.61
2.6
2.5
—
—
—
0
0
254
1747
1.55
8.60
2.6
1.9
29.12
29.68
s
1.14
247
1689
67
310
2.22
8.29
1.5
1.3
—
—
—
0
0
151
922
1.71
8.25
5.0
3.5
88.12
86.30
ng/l
0.10
127
799
1281
11980
1.70
8.22
23.5
16.4
139.36
139.63
mmol/l
3.15
1253
11646
43
163
2.69
8.18
2.1
1.6
—
—
—
0
0
393
2984
1.44
8.13
3.3
2.6
4197.59
6086.97
umol/l
0.39
342
2590
84
428
2.02
8.12
2.7
2.6
3.03
3.01
g/l
0.06
77
388
1283
12010
1.70
8.12
23.8
16.5
3.96
3.97
mmol/l
0.43
1254
11652
314
2286
1.48
8.08
1.9
1.8
1291.91
1179.76
nmol/l
1.44
251
1699
36
126
2.91
7.94
2.3
1.7
—
—
—
0
0
269
1904
1.51
7.94
2.2
1.8
—
—
—
0
0
201
1334
1.59
7.92
2.2
1.8
—
—
—
0
0
17
22
7.81
7.88
1.4
1.0
—
—
—
0
0
16
19
8.50
7.82
1.4
1.0
—
—
—
0
0
1190
10965
1.52
7.80
19.8
13.3
79.48
79.75
ml/min/173m2
0.15
1022
9068
33
112
2.99
7.69
4.5
3.7
—
—
—
0
0
557
4530
1.38
7.63
4.6
3.6
43.81
44.77
ng/l
0.02
397
3154
198
1321
1.58
7.62
2.1
1.7
—
—
—
0
0
45
182
2.52
7.54
1.3
1.2
257.45
242.65
u/ml
0.17
31
105
813
7029
1.37
7.52
3.2
2.9
—
—
—
0
0
220
1509
1.54
7.49
8.7
5.1
1.05
1.03
mmol/l
0.32
207
1383
59
271
2.23
7.46
2.1
1.6
—
—
—
0
0
29
93
3.16
7.43
1.7
1.7
—
—
—
0
0
38
143
2.70
7.35
2.0
2.1
33.21
32.42
pg
0.58
38
143
1303
12304
1.71
7.24
15.6
10.3
25.76
25.31
u/l
0.38
1270
11853
342
2581
1.43
7.19
1.8
1.7
480.64
15297342.19
pmol/l
1.57
286
2105
23
65
3.58
7.16
3.3
3.1
41.85
41.01
%
0.06
13
37
24
70
3.47
7.13
1.0
1.3
—
390.00
—
0
8
88
478
1.90
7.10
2.1
1.9
1.90
1.85
ug/l
0.01
79
417
80
421
1.95
7.09
2.4
2.5
10.57
10.30
g/l
0.16
73
379
18
30
6.06
7.08
1.9
2.3
—
—
—
0
0
94
523
1.85
7.04
3.1
1.8
1.52
1.53
g/l
0.03
78
465
460
3667
1.38
6.99
2.9
2.4
58.32
79.72
u/l
0.48
424
3392
72
370
2.00
6.83
2.5
2.5
37.99
37.55
g/l
0.29
65
330
67
336
2.04
6.80
2.6
2.6
0.00
0.00
g/l
-0.00
62
311
162
1060
1.60
6.76
2.9
2.4
34.83
86.94
u/l
0.60
141
902
52
237
2.24
6.72
1.3
1.4
—
—
—
0
0
52
237
2.24
6.72
1.3
1.4
—
—
—
0
0
327
2488
1.41
6.49
5.9
4.1
1.01
1.02
kg/l
0.73
26
364
331
2528
1.40
6.42
1.3
1.2
0.71
1.63
u/ml
2.60
88
675
337
2583
1.40
6.40
2.7
1.7
1.30
1.17
mg/l
0.29
270
1958
116
709
1.69
6.33
1.4
1.2
178.58
173.51
u/ml
0.03
104
652
159
1055
1.57
6.25
5.6
3.3
1.56
1.95
mmol/l
0.71
134
876
187
1289
1.52
6.19
3.8
2.6
9.86
7.71
umol/l
0.39
167
1107
19
53
3.62
6.05
3.1
2.8
1074.00
1091.26
u/ml
0.01
19
53
646
5515
1.31
5.94
2.8
2.5
—
—
—
0
0
151
1002
1.57
5.94
7.4
6.4
1.22
1.40
mmol/l
1.87
145
976
22
70
3.18
5.75
1.1
1.2
—
—
—
0
0
248
1837
1.42
5.68
1.5
1.5
—
—
—
0
0
187
1318
1.48
5.56
7.0
6.8
5.04
5.10
kpa
0.31
177
1260
187
1318
1.48
5.56
7.0
6.8
12.85
12.05
kpa
1.07
176
1263
118
753
1.62
5.47
2.3
2.4
8.78
26.34
au/ml
—
5
60
129
846
1.58
5.35
2.2
1.6
—
—
—
0
0
186
1320
1.47
5.34
7.0
6.9
1.29
1.18
mmol/l
0.11
148
1049
148
1002
1.53
5.33
2.6
2.4
5.03
6.97
ug/l
1.65
121
882
1338
12851
1.70
5.32
31.9
20.9
4.39
4.45
e12/l
4.94
1309
12465
54
276
1.99
5.27
1.6
1.5
—
—
—
0
0
1338
12855
1.70
5.26
32.1
21.1
132.55
133.98
g/l
3.29
1321
12645
49
242
2.06
5.25
1.8
1.4
—
—
—
0
0
159
1097
1.51
5.24
2.2
2.2
0.22
0.21
g/l
0.54
149
1032
66
362
1.86
5.24
1.4
1.1
—
—
—
0
0
168
1174
1.49
5.21
7.3
7.2
95.77
95.45
%
0.29
160
1130
70
392
1.83
5.20
3.0
3.0
—
—
—
0
0
20
64
3.16
5.20
1.1
1.1
—
—
—
0
0
11
15
7.38
5.14
2.2
4.9
—
—
—
0
0
1337
12851
1.68
5.14
31.9
21.0
6.66
6.68
e9/l
0.14
1309
12463
1336
12839
1.68
5.14
31.7
21.0
39.74
39.74
%
0.01
1275
11987
106
673
1.62
5.03
1.3
1.3
44.54
50.13
au/ml
—
5
43
31
129
2.43
4.99
2.1
1.5
—
—
—
0
0
15
41
3.69
4.93
1.5
1.5
—
—
—
0
0
176
1257
1.46
4.89
4.6
3.4
—
—
—
0
0
1335
12846
1.65
4.86
32.0
20.9
250.04
252.08
e9/l
0.54
1307
12499
46
230
2.03
4.79
2.3
2.5
15.17
15.93
%
0.61
22
119
64
360
1.81
4.72
1.4
1.1
—
—
—
0
0
65
372
1.78
4.54
3.8
3.7
122.52
68.27
mg/l
0.43
53
305
93
588
1.62
4.52
8.9
9.0
24.10
24.36
mmol/l
0.24
88
570
65
374
1.77
4.46
3.8
3.7
47.71
48.85
mg/l
0.03
54
307
834
7525
1.26
4.39
3.3
3.1
52.96
47.78
u/l
0.65
777
6981
38
183
2.11
4.39
1.9
1.6
—
—
—
0
0
38
183
2.11
4.39
1.9
1.6
—
—
—
0
0
129
886
1.50
4.37
4.8
2.6
4.53
4.46
kpa
0.15
124
854
63
362
1.77
4.35
3.2
3.7
59.61
1.86
ratio
—
10
34
35
165
2.15
4.27
1.3
1.2
10.62
5.03
u/ml
0.33
13
65
84
526
1.63
4.25
6.2
3.5
52.98
47.32
%
1.38
84
519
23
90
2.58
4.23
2.2
1.6
—
—
—
0
0
18
62
2.93
4.18
1.3
1.1
—
—
—
0
0
1139
10710
1.32
4.17
6.6
5.7
39.94
39.93
mmol/mol
0.01
1069
9858
55
311
1.80
4.03
3.7
2.1
175.94
189.28
%
0.52
50
295
27
118
2.31
3.95
2.1
1.5
—
—
—
0
0
8
11
7.31
3.86
1.3
3.3
—
—
—
0
0
34
166
2.07
3.83
1.3
1.2
9.22
3.44
u/ml
—
9
43
50
280
1.81
3.79
1.2
1.1
—
—
—
0
0
130
922
1.45
3.77
2.5
2.6
63.89
65.79
ml/min/173m2
0.22
55
391
34
167
2.06
3.77
1.1
1.1
—
—
—
0
0
31
147
2.13
3.76
2.2
1.5
—
—
—
0
0
24
102
2.38
3.75
1.7
1.5
—
—
—
0
0
24
102
2.38
3.75
1.7
1.5
—
—
—
0
0
24
102
2.38
3.75
1.7
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
67
2.71
3.66
1.1
1.2
—
—
—
0
0
59
351
1.71
3.66
2.1
1.7
—
—
—
0
0
424
3598
1.25
3.64
3.7
3.1
6.82
7.19
mmol/l
0.95
355
3017
50
284
1.79
3.64
1.5
1.3
—
—
—
0
0
47
262
1.82
3.63
1.3
1.5
1658.16
607.70
e6/l
0.29
38
209
47
262
1.82
3.63
1.3
1.4
10.08
7.74
e6/l
0.20
38
201
1221
11652
1.34
3.61
5.4
4.9
2.73
2.75
mmol/l
0.46
1137
10681
345
2862
1.27
3.58
2.6
2.2
—
—
—
0
0
34
171
2.01
3.56
2.1
1.4
—
—
—
0
0
1200
11435
1.32
3.49
4.9
4.4
4.67
4.69
mmol/l
0.22
1124
10547
10
22
4.57
3.43
1.5
2.0
7.61
10.65
mg/l
—
10
15
10
22
4.57
3.43
1.2
1.0
—
—
—
0
0
13
42
3.11
3.37
1.1
1.1
—
—
—
0
0
22
95
2.34
3.34
1.4
1.0
—
—
—
0
0
16
59
2.73
3.33
1.1
1.1
1.14
1.05
ratio
—
6
23
21
89
2.38
3.32
1.5
1.1
—
—
u/ml
—
0
0
276
2247
1.28
3.31
4.0
3.7
123.58
401.75
ng/l
3.17
206
1759
25
115
2.19
3.29
1.2
1.2
59.32
53.92
u/l
0.22
25
104
16
60
2.69
3.23
1.2
1.4
—
—
—
0
0
16
60
2.69
3.23
1.2
1.4
—
—
—
0
0
31
157
2.00
3.21
2.0
1.3
—
—
—
0
0
364
3076
1.25
3.19
1.7
1.6
1.42
1.36
mmol/l
0.73
303
2574
1189
11348
1.29
3.18
4.8
4.4
1.49
1.49
mmol/l
0.09
1103
10403
100
700
1.46
3.14
2.0
1.5
—
—
—
0
0
13
40
3.27
3.14
1.2
1.1
1634.00
1663.33
miu/ml
0.03
13
40
80
537
1.52
3.08
2.0
1.8
—
—
—
0
0
7
12
5.86
3.02
1.4
1.4
—
—
—
0
0
11
31
3.57
2.99
3.5
1.9
—
—
—
0
0
26
127
2.07
2.98
2.0
1.6
—
—
—
0
0
26
127
2.07
2.98
2.0
1.6
—
—
—
0
0
1181
11294
1.27
2.89
5.2
4.6
5.91
5.94
mmol/l
0.33
1082
10223
21
96
2.21
2.84
1.6
2.3
15.86
5.98
umol/l
0.45
15
64
35
194
1.82
2.81
1.2
1.2
—
—
—
0
0
55
348
1.60
2.77
1.6
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
56
356
1.60
2.76
6.5
2.6
0.34
0.38
u/ml
0.36
31
205
7
14
5.02
2.73
2.0
2.4
—
—
—
0
0
8
19
4.23
2.68
2.8
1.1
85.88
102.53
%
—
8
19
21
100
2.12
2.59
1.7
1.4
28.40
29.14
%
0.03
14
63
391
3399
1.21
2.54
3.8
3.2
208.99
333.88
mg/l
0.32
261
2114
1148
10987
1.23
2.51
4.3
3.9
1.30
1.29
mmol/l
0.25
1050
9989
411
3599
1.20
2.47
4.6
3.8
10.33
8.56
mg/mmol
0.32
270
2208
22
109
2.03
2.47
2.5
2.2
—
—
—
0
0
83
590
1.43
2.46
1.6
1.3
—
—
—
0
0
44
272
1.64
2.46
1.8
1.7
11438.74
15230.44
e6/l
0.23
31
201
17
76
2.25
2.44
2.6
1.4
—
—
—
0
0
10
32
3.14
2.43
1.1
1.3
—
—
—
0
0
6
12
5.02
2.40
2.0
1.7
—
—
—
0
0
5
8
6.27
2.37
1.2
1.1
—
—
—
0
0
22
112
1.98
2.31
4.0
2.4
—
—
—
0
0
61
414
1.49
2.30
2.0
1.7
—
—
—
0
0
96
712
1.37
2.25
1.9
1.6
—
—
—
0
0
6
14
4.30
2.15
1.5
1.1
—
—
—
0
0
97
727
1.36
2.14
4.1
3.5
5.14
5.16
kpa
0.08
90
699
28
159
1.78
2.14
1.2
1.1
—
—
—
0
0
104
789
1.34
2.13
1.2
1.2
126.44
136.10
iu/ml
0.10
35
305
18
88
2.06
2.11
1.2
1.2
—
—
—
0
0
94
705
1.36
2.08
3.3
3.3
4.24
4.49
pmol/l
1.67
83
623
8
26
3.09
2.01
1.1
1.3
—
—
—
0
0
14
63
2.23
2.01
2.9
1.5
—
—
—
0
0
14
63
2.23
2.01
2.9
1.5
—
—
—
0
0
6
16
3.76
1.93
1.2
1.1
—
—
—
0
0
39
251
1.57
1.91
2.1
2.1
119.32
128.52
g/l
1.22
25
187
72
966
0.73
1.84
1.7
1.7
—
—
—
0
0
6
17
3.54
1.84
1.2
1.1
—
—
—
0
0
86
650
1.34
1.84
2.6
2.2
13.42
12.52
nmol/l
0.49
74
587
90
689
1.33
1.77
4.1
3.5
1.41
1.89
mmol/l
0.49
64
526
176
1466
1.23
1.76
9.5
7.2
—
—
—
0
0
26
155
1.69
1.73
1.1
1.1
0.20
2.61
u/ml
2.21
13
77
21
118
1.79
1.70
1.1
1.1
—
—
—
0
0
11
48
2.30
1.70
1.2
1.3
—
—
—
0
0
12
55
2.19
1.67
1.3
2.1
—
—
—
0
0
7
25
2.81
1.65
2.4
1.1
—
—
—
0
0
20
112
1.80
1.65
1.1
1.0
0.15
0.63
u/ml
—
7
35
15
76
1.98
1.64
1.4
1.5
75.07
80.86
umol/l
0.48
15
76
44
303
1.47
1.62
1.5
1.8
2.57
4.75
iu/l
2.40
17
104
24
143
1.69
1.61
1.2
1.4
33.61
27.46
u/l
0.39
19
118
12
57
2.11
1.55
1.7
1.5
—
—
—
0
0
12
57
2.11
1.55
1.7
1.5
—
—
—
0
0
21
122
1.73
1.55
1.1
1.1
—
—
—
0
0
7
27
2.60
1.51
2.1
1.1
—
—
—
0
0
49
351
1.41
1.49
1.6
1.5
232.30
293.63
ug/g
1.56
27
206
221
1917
1.18
1.46
1.5
1.4
—
—
—
0
0
27
171
1.59
1.46
1.2
1.1
—
—
—
0
0
10
45
2.23
1.46
3.9
4.4
—
—
—
0
0
21
125
1.69
1.44
1.5
1.9
—
1506.67
—
0
6
120
983
1.24
1.44
3.8
3.0
179.12
209.45
ng/l
0.41
106
893
9
40
2.26
1.40
1.3
1.1
0.30
0.31
g/l
—
9
32
9
40
2.26
1.40
1.7
2.8
—
—
—
0
0
9
40
2.26
1.40
1.7
2.8
—
—
—
0
0
7
29
2.42
1.39
2.1
1.1
—
—
—
0
0
13
67
1.95
1.38
1.3
1.1
120.85
71.30
u/l
1.11
13
57
59
443
1.35
1.37
3.0
3.4
73.07
786.06
u/ml
1.29
50
380
74
575
1.30
1.37
5.7
3.1
25.34
25.45
mmol/l
0.12
74
555
5
17
2.95
1.36
1.8
1.2
—
—
—
0
0
15
82
1.84
1.36
1.1
1.1
—
—
—
0
0
0
38
0.00
1.34
0.0
1.2
—
289.38
—
0
26
148
1253
1.20
1.30
3.5
4.2
5.41
20.54
ug/l
1.42
122
1029
6
24
2.51
1.30
1.0
1.1
—
—
—
0
0
10
48
2.09
1.28
2.2
2.6
28220.80
41629.27
ug/l
—
10
48
8
35
2.29
1.27
1.5
1.2
—
—
—
0
0
8
35
2.29
1.27
1.5
1.2
—
—
—
0
0
9
45
2.01
1.23
1.0
1.0
—
—
—
0
0
5
19
2.64
1.21
1.0
1.0
—
—
—
0
0
28
190
1.48
1.17
1.2
1.1
0.48
2.29
u/ml
1.54
15
98
41
300
1.38
1.15
1.5
1.4
—
—
—
0
0
12
65
1.85
1.13
1.3
1.2
74.75
13.76
u/l
0.78
12
54
43
321
1.35
1.08
1.3
1.2
—
—
—
0
0
36
261
1.39
1.08
4.5
3.5
25.48
25.26
mg/l
0.02
24
164
30
211
1.43
1.06
2.3
1.5
—
—
—
0
0
125
1460
0.84
1.06
5.0
4.5
32.14
32.42
%
0.11
93
977
10
52
1.93
1.06
1.1
1.4
167.48
174.48
pmol/l
—
10
52
7
33
2.13
1.05
1.3
1.2
—
—
—
0
0
9
46
1.96
1.03
1.9
1.6
—
—
—
0
0
9
46
1.96
1.03
1.9
1.6
—
—
—
0
0
9
46
1.96
1.03
1.9
1.6
—
—
—
0
0
7
34
2.06
1.03
1.3
1.1
—
—
—
0
0
7
34
2.06
1.03
1.3
1.1
—
—
—
0
0
20
130
1.55
1.03
1.3
1.3
1184.85
1877.24
e6/l
0.67
13
87
17
107
1.60
1.00
1.1
1.1
—
—
—
0
0
5
23
2.18
0.98
1.0
1.2
—
—
—
0
0
12
69
1.75
0.96
1.8
1.1
—
—
—
0
0
12
70
1.72
0.92
1.8
1.1
—
—
—
0
0
17
256
0.66
0.92
1.4
1.5
—
—
—
0
0
38
289
1.32
0.88
3.0
2.1
4478.30
2675.71
u/l
0.30
14
116
10
56
1.79
0.88
1.0
1.0
—
—
—
0
0
10
56
1.79
0.88
1.1
1.1
—
—
—
0
0
8
43
1.87
0.87
5.5
1.9
—
—
—
0
0
106
909
1.18
0.87
1.9
1.9
—
—
—
0
0
24
170
1.42
0.85
1.4
1.6
—
—
—
0
0
10
57
1.76
0.83
2.3
2.5
—
—
—
0
0
8
46
1.74
0.82
3.5
2.1
14.36
193.92
ug/l
—
8
40
255
2335
1.11
0.81
4.4
4.3
22.51
21.43
%
0.51
134
1112
314
2908
1.10
0.80
4.8
5.0
2.05
2.84
ug/l
1.35
289
2579
35
268
1.31
0.79
5.9
2.9
1.52
1.54
mmol/l
0.06
35
261
116
1011
1.16
0.79
2.1
2.0
—
—
—
0
0
17
114
1.50
0.79
1.2
1.6
—
—
—
0
0
8
48
1.67
0.78
1.4
1.1
—
—
—
0
0
17
115
1.48
0.77
1.3
1.3
16072.86
38983.77
e6/l
—
7
62
67
559
1.21
0.76
1.1
1.0
—
—
—
0
0
0
28
0.00
0.76
0.0
1.2
—
175.69
—
0
20
19
132
1.45
0.76
1.4
1.6
68.89
60.60
%
—
9
87
10
59
1.70
0.76
3.9
3.8
—
—
—
0
0
53
432
1.24
0.75
1.8
1.7
4.55
4.28
mg/l
0.05
35
323
12
75
1.61
0.75
3.4
1.7
—
—
—
0
0
140
1245
1.14
0.74
1.8
1.7
1.50
1.47
%
0.18
124
1095
19
133
1.43
0.73
1.7
1.5
—
—
—
0
0
16
108
1.49
0.73
3.8
4.8
144.47
51.40
u/ml
—
6
35
17
117
1.46
0.72
1.6
1.3
2142.33
163775.66
e6/l
1.17
12
80
12
76
1.58
0.71
1.4
2.0
—
—
—
0
0
21
153
1.38
0.67
1.1
1.0
0.63
1.76
u/ml
—
6
65
21
153
1.38
0.67
1.4
1.5
0.45
0.34
nmol/l
0.31
16
118
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
56
470
1.20
0.63
2.3
1.9
—
—
—
0
0
32
252
1.28
0.63
6.3
3.0
7.77
7.52
mmol/l
0.30
32
246
0
20
0.00
0.60
0.0
2.1
—
0.95
—
0
14
15
105
1.43
0.60
1.1
1.2
—
—
—
0
0
11
72
1.53
0.59
1.2
1.1
1.07
1.12
u/l
—
6
39
6
36
1.67
0.56
3.0
1.3
7.65
8.72
ug/l
—
6
36
28
222
1.27
0.54
1.8
1.6
—
—
—
0
0
11
74
1.49
0.53
1.1
1.0
720.00
671.80
ng/l
—
6
45
9
64
1.41
0.51
1.1
1.4
—
—
—
0
0
20
156
1.29
0.45
1.3
1.1
—
—
—
0
0
31
258
1.21
0.42
1.6
1.4
6.54
10.95
u/l
2.28
24
207
10
139
0.72
0.42
1.9
1.3
6.60
7.27
mmol/l
—
10
119
50
435
1.15
0.41
2.1
1.8
—
—
—
0
0
29
348
0.83
0.41
2.0
1.7
—
—
—
0
0
12
88
1.37
0.40
1.2
1.1
50.67
37.71
mg/l
0.43
12
73
33
281
1.18
0.36
1.3
1.5
208.48
216.83
pmol/l
0.02
33
275
15
117
1.29
0.35
1.2
1.5
—
—
—
0
0
35
301
1.17
0.35
1.5
1.3
238.15
246.96
miu/ml
0.05
13
149
19
232
0.82
0.33
1.5
1.5
—
—
—
0
0
6
45
1.33
0.33
1.5
1.8
—
—
—
0
0
6
45
1.33
0.33
1.0
1.1
116.60
207.28
iu/ml
—
6
45
18
221
0.81
0.33
1.4
1.4
—
—
—
0
0
18
221
0.81
0.33
1.4
1.4
—
—
—
0
0
18
220
0.82
0.32
1.4
1.4
—
—
—
0
0
18
220
0.82
0.32
1.4
1.4
—
—
—
0
0
21
175
1.20
0.30
1.0
1.1
34.29
89.19
iu/ml
—
7
39
8
63
1.27
0.27
1.3
1.1
—
—
—
0
0
50
457
1.10
0.23
5.0
3.9
24.07
24.90
mmol/l
1.01
43
426
7
95
0.74
0.22
2.1
1.5
0.68
0.98
g/l
—
7
95
26
294
0.88
0.21
3.1
3.3
0.80
0.81
nmol/l
0.06
20
228
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
11.50
—
0
12
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
176
1691
1.05
0.21
3.2
3.0
0.68
0.78
ug/l
1.23
125
1085
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
13
155
0.84
0.20
2.1
1.3
—
—
—
0
0
44
404
1.09
0.19
1.6
1.4
—
—
—
0
0
52
482
1.08
0.19
1.4
1.4
35.27
30.30
iu/l
0.45
44
412
5
66
0.76
0.17
1.2
1.2
—
—
—
0
0
31
283
1.10
0.16
2.6
2.3
65.73
126.97
ug/min
0.63
20
179
10
83
1.21
0.15
1.2
1.0
293.20
286.15
mg/l
—
10
71
34
369
0.92
0.15
1.6
1.5
—
—
—
0
0
12
103
1.17
0.13
1.2
1.3
—
—
—
0
0
13
146
0.89
0.10
1.1
1.1
—
—
—
0
0
14
155
0.90
0.09
2.0
1.4
—
—
—
0
0
14
155
0.90
0.09
2.0
1.4
—
—
—
0
0
6
55
1.09
0.09
1.0
1.3
—
—
—
0
0
14
153
0.91
0.07
2.0
1.4
—
—
—
0
0
14
152
0.92
0.06
2.0
1.4
—
—
—
0
0
14
152
0.92
0.06
2.0
1.4
—
—
—
0
0
37
364
1.02
0.00
1.8
1.5
—
—
—
0
0
24
236
1.02
0.00
2.6
1.8
1.31
0.91
nmol/l
0.76
17
195
15
152
0.99
0.00
2.7
2.6
12.20
31.73
mg/l
—
5
39
16
162
0.99
0.00
1.6
1.5
—
—
—
0
0
15
145
1.03
0.00
1.6
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
7.64
—
0
5
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
37.68
—
0
5
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
20.36
—
0
5
0
5
0.00
0.00
0.0
1.2
—
1.00
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
6
65
0.92
-0.00
1.7
1.3
—
—
—
0
0
26
260
1.00
-0.00
1.6
1.3
—
—
—
0
0
5
49
1.02
-0.00
1.4
1.8
2.90
8.22
nmol/l
—
5
43
0
9
0.00
-0.00
0.0
1.7
—
—
—
0
0
6
65
0.92
-0.00
1.7
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
51
0.98
-0.00
1.8
1.2
—
—
—
0
0
5
51
0.98
-0.00
1.8
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
2.50
—
0
6
Mortality – FinRegistry
↥Association
Association between endpoint H7_KERATITISINOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_KERATITISINOTH | 1.172 [1.06, 1.3] | 0.003 |
| Birth year | 0.997 [0.99, 1.01] | 0.498 |
During the follow-up period (1.1.1998 — 31.12.2019), 1256 out of 5773 females with H7_KERATITISINOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_KERATITISINOTH | 1.287 [1.12, 1.47] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 808 out of 3332 males with H7_KERATITISINOTH died.
Mortality risk
Mortality risk for people of age
years, who have H7_KERATITISINOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.122% | 0.217% |
| 5 | 0.79% | 1.381% |
| 10 | 1.877% | 3.322% |
| 15 | 3.525% | 6.138% |
| 20 | 6.137% | 10.284% |
Relationships between endpoints
↥Index endpoint: H7_KERATITISINOTH – Keratitis and keratoconjunctivitis in other diseases classified elsewhere
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data